REFERENCES
1. Montgomery C, Couch C, Emory CL, Nicholas R. Giant Cell Tumor of Bone: Review of Current Literature, Evaluation, and Treatment Options. J Knee Surg. 2019;32(4):331-336.
2. Rosa D, Dias RB, Salvador JC, Borges A. Recurrent giant cell tumour of the maxillary sinus and pterygoid process treated with denosumab. BMJ Case Rep. 2018;2018:1-6.
3. Mohaidat ZM, Al-jamal HZ, Bany-Khalaf AM, Radaideh AM, Audat ZA. Giant cell tumor of bone: Unusual features of a rare tumor. Rare Tumors. 2019;11. doi:10.1177/2036361319878894
4. Sobti A, Agrawal P, Agarwala S, Agarwal M. Giant cell tumor of bone - An overview. Arch Bone Jt Surg. 2016;4(1):2-9.
5. di Carlo FS, Whyte MP & Gianfrancesco F. The two faces of giant cell tumor of bone. Cancer Letters. 2020;489:1-8.
6. Luengo-Alonso G, Mellado-Romero M, Shemesh S, Ramos-Pascua L, Pretell-Mazzini J. Denosumab treatment for giant-cell tumor of bone: a systematic review of the literature. Archives of orthopaedic and trauma surgery. 2019;139(10):1339-1349.
7. Board WC of TE. Soft Tissue and Bone Tumours. 5th ed. Lyon (France): International Agency for Research on Cancer; 2020.
8. Wülling, M., Engels, C., Jesse, N., Werner, M., Delling, G., & Kaiser, E. The nature of giant cell tumor of bone. Journal of cancer research and clinical oncology. 2001;127(8):467-474.
9. Tuluc M., Zhang X, & Inniss, S. Giant cell tumor of the nasal cavity: case report. European archives of oto-rhino-laryngology. 2007;264(2):205-208.
10. Kumar R, Bharani V, Gupta N, et al. Giant cell tumour of tendon sheath: A 10-year study from a tertiary care centre. Cytopathology. 2018;29(3):288-293.
11. Amary F, Berisha F, Ye H, Gupta M, Gutteridge A, et al. H3F3A (Histone 3.3) G34W immunohistochemistry: a reliable marker defining benign and malignant giant cell tumor of bone. The American journal of surgical pathology. 2017;41(8):1059.
12. Errani C, Tsukamoto S, Leone G, Righi A, Akahane M. et al. Denosumab may increase the risk of local recurrence in patients with giant-cell tumor of bone treated with curettage. JBJS. 2018; 100(6):496-504.
13. Tsukamoto S, Tanaka Y, Mavrogenis A. F, Kido A, Kawaguchi M et al. Is treatment with denosumab associated with local recurrence in patients with giant cell tumor of bone treated with curettage? A systematic review. A Publication of The Association of Bone and Joint Surgeons®| CORR®. 2020;478(5):1076-1085.
14. Kato I, Furuya M, Matsuo K, Kawabata Y, Tanaka R. et al. Giant cell tumours of bone treated with denosumab: histological, immunohistochemical and H3F3A mutation analyses. Histopathology. 2018;72(6):914-922.
.